We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Attorneys: Pending Appeals Case Could Shift FDA’s Guidance Policy
Attorneys: Pending Appeals Case Could Shift FDA’s Guidance Policy
December 30, 2011
Drugmakers dissatisfied with the FDA’s use of guidances as a form of policymaking could find relief with a case pending appeal in the U.S. Court of Appeals for the Eleventh Circuit, industry attorneys tell WDL.